38 Investor presentation First three months of 2021 Diabetes is a chronic disease requ intensification over time Diet and exercise 1 OAD GLP-1 -cell function Insulin Time Note: Patient distribution across treatment classes is indicative and based on data for the USA, Germany and France. Other OADs Source: IQVIA PharMetrix claims data, IQVIA disease analyser, IQVIA MIDAS; value figures based on IQVIA MAT, Feb 2021 OAD: Oral anti-diabetic
Download PDF file